Close

Analyst Ratings for Amylin Pharmaceuticals (AMLN) [Buys]

All Latest Ratings for AMLN

AMLN Rating Summary

  |   Expand Research on AMLN
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 2.3 / 10   Percentile Rank: 15%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/16/2012 Credit Suisse N/A New Coverage Outperform
(N/A)		 22.00
(N/A)		 17.61
(30.98)		 75.92% Details
12/7/2011 Seaport Global Securities N/A New Coverage
(N/A)		 14.00
(N/A)		 10.79
(30.98)		 187.12% Details